273
Participants
Start Date
January 7, 2018
Primary Completion Date
August 3, 2018
Study Completion Date
December 31, 2018
Insulin Degludec U100
Patients on any basal insulin including insulin glargine will be randomised and converted to basal degludec insulin
Insulin Glargine
Patients on any basal insulin including insulin glargine will be randomised and either glargine will be continued or will beconverted to basal glargine insulin
Hamad Medical Corporation, Doha
Collaborators (1)
Novo Nordisk A/S
INDUSTRY
Weill Cornell Medical College in Qatar
OTHER